Search

An interesting set of deals bring together major companies and the Engineering and Physical Sciences Research Council in a new model for academic/industry collaboration.

The UK government said it will contribute £16 million to a £32 million programme aimed at ensuring the safe operation of unmanned aviation vehicles (UAV) in civil airspace.

The GREAT Consortium has been set up to design a mass market receiver for Galileo, Europe's new global satellite navigation system that is due to come into operation in 2012.

Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans.

PharmaLinks, a business dedicated to commercialising pharmaceutical research, is looking for a development partner for an immunosuppressive cytokine with therapeutic potential in inflammatory diseases including rheumatoid arthritis, asthma, COPD and arteriosclerosis.

How will Imperial College London's newly floated tech-transfer affiliate invest its stock-market millions? After raising the money, now comes the fun part: spending it.

Merlin Biosciences has been under the cloud of an investigation by the UK's Serious Fraud Office. Now founder Chris Evans says the firm is planning new investments.

Biotech start-ups in France and elsewhere in Europe make a unique and important contribution to healthcare. They merit special treatment to help them grow.

Yochai Benkler and Lawrence Lessig are two well-known law professors affiliated with very prestigious US universities, Yale and Stanford, respectively. They are specialised in intellectual property like policemen are specialised in crime: it is their bailiwick but they do not particularly like it.

The IP battlefield is large and diversified. It goes way beyond highly-publicized battles about patenting genes or semi-conductor designs. A case in point is a lawsuit filed July 14 by Materialise nv, a spin-off of Belgium’s Katholieke Universiteit Leuven, against a Swiss-Swedish company, Nobel Biocare.

You have until the end of the month to tell the EU about your "needs in relation to transnational research cooperation and knowledge transfer between public research organisations".

Medical research should benefit from new lectureships for experts in clinical trials.

The technology-transfer unit of Imperial College London, continuing preparations for its stock-market debut on 31 July, said it has completed a £25 million private placement and set a public share price that would value the business at £181 million.

The pressing need for alternative energy sources is driving investment into nanotechnology devices for energy applications such as photovoltaic solar cells.

Researchers developing compounds designed to prevent allergens from entering the body are seeking investment to move to the next stage of development.

Two companies that began life in laboratories at Cambridge University have merged to form a new medical diagnostics company, to be called Pronostics Ltd.

The stock-market debut at the end of July of Imperial College London’s tech-transfer office is the best news for academic reform in years.

China has now set its sights on developing its scientific prowess in the same way - and at the same rate – as it has modernised its economy.

Imperial College London is set to become the first university to float its technology-transfer office directly on the stock market.

On Tuesday the UK became the latest country to jump back on the nuclear energy bandwagon. But 20 years after Chernobyl, how easy is it to turn on the nuclear tap?